The American Center for Disease Prevention and Control announced its approval of the first drug intended to treat…
It is expected that this announcement will be a major shift for migraine patients in the absence of any curative medication for them.
This medication, called Aimovig, is a monthly injection that’s similar to a device, which works to stop a specific protein (CGRP) responsible for permanent migraines.
In turn, the neurologist and sister specialist, Dr. Amaal Starling, indicated that this drug will have a significant impact in treating migraine patients.
Millions of people suffer from acute migraine around the world without a drug that treats it. All available medications relieve the symptoms and severity of the attack, nothing more.
Migraine is the third most prevalent disease around the world, and it is also among the tenth largest causes of disability in the world as well.
A migraine attack not only includes a headache, but is accompanied by nausea, vomiting, and many different symptoms. Unfortunately, this attack lasts from several hours to consecutive days.
Use of medications available to treat migraine symptoms can sometimes be worse for patients due to associated side effects such as brain fog, weight gain, loss of libido, and dry mouth.
As for the new drug, it has been working on it since ancient times, and researchers noticed that people with migraine have high levels of the aforementioned protein, so this drug targets the protein itself.
It is expected that the drug will start trading in the market soon.